Low toxicity immunosuppressive protocols in renal transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Pharmacology

Background:

• Renal transplantation outcomes have improved with potent immunosuppressants.
• Long-term immunosuppression is necessary but associated with significant toxicities.
• Established and newer immunosuppressive agents (cyclosporine, tacrolimus, mycophenolate mofetil, sirolimus) have known side effects.

Purpose of the Study:

• To review various low-toxicity protocols in clinical renal transplantation.
• To evaluate strategies for minimizing immunosuppression-related side effects.
• To present preliminary outcomes of a novel tolerogenic protocol.

Main Methods:

• Categorization of low-toxicity protocols: calcineurin inhibitor withdrawal/minimization/avoidance, steroid withdrawal/avoidance, and adjunctive agent withdrawal.
• Review of existing clinical renal transplantation protocols.
• Description of a new tolerogenic protocol involving steroid avoidance and calcineurin inhibitor tapering.

Main Results:

• Several low-toxicity protocols have been developed and utilized in renal transplantation.
• The optimal low-toxicity regimen for efficacy and safety remains unclear.
• A novel tolerogenic protocol shows promise across multiple solid organ transplants.

Conclusions:

• Minimizing immunosuppression toxicity is a key goal in transplantation.
• Various low-toxicity strategies are being explored to balance efficacy and safety.
• A promising new tolerogenic protocol combines steroid avoidance with calcineurin inhibitor management.